Your browser doesn't support javascript.
Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana.
Shava, Emily; Izu, Alane; Gaolathe, Tendani; Walker, Adam; Carty, Lucy; Georgiou, Panayiotis; Kuate, Lesego; Kgathi, Coulson; Sekoto, Tumalano; Seonyatseng, Ngozana; Mogashoa, Tuelo; Maphorisa, Comfort; Mohammed, Terence; Ntalabgwe, Tshenolo; Frank, Tshepho T; Matlhaku, Boitumelo; Diphoko, Ame; Phindela, Thandie; Kaunda, Agripa; Kgari, Poloko; Kanyakula, Thomas; Palalani, Gape; Phakedi, Isabella; Taylor, Sylvia; Mmalane, Mompati; Moyo, Sikhulile; Makhema, Joseph.
  • Shava E; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: emakunike@gmail.com.
  • Izu A; South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vacci
  • Gaolathe T; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, United States; University of Botswana, Gaborone, Botswana. Electronic address: gaolathet@gmail.com.
  • Walker A; Medical Evidence, Vaccine and Immune Therapies, BioPharmaceuticals Medicine, AstraZeneca, Cambridge, UK. Electronic address: adam.walker@astrazeneca.com.
  • Carty L; Medical and Payer Evidence Statistics, BioPharmaceuticals Medicine, AstraZeneca, Cambridge, UK. Electronic address: lucy.carty@astrazeneca.com.
  • Georgiou P; Late Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. Electronic address: panos.georgiou@astrazeneca.com.
  • Kuate L; Ministry of Health Botswana, Botswana. Electronic address: drkuate@gmail.com.
  • Kgathi C; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: ckgathi@bhp.org.bw.
  • Sekoto T; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: tsekoto@bhp.org.bw.
  • Seonyatseng N; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: nseonyatseng@bhp.org.bw.
  • Mogashoa T; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: tmogashoa@bhp.org.bw.
  • Maphorisa C; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: cmaphorisa@bhp.org.bw.
  • Mohammed T; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: tmohammed@bhp.org.bw.
  • Ntalabgwe T; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: tntalabgwe@bhp.org.bw.
  • Frank TT; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: tfrank@bhp.org.bw.
  • Matlhaku B; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: bmatlhaku@bhp.org.bw.
  • Diphoko A; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: adiphoko@bhp.org.bw.
  • Phindela T; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: tphindela@bhp.org.bw.
  • Kaunda A; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: akaunda@bhp.org.bw.
  • Kgari P; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: pkgari@bhp.org.bw.
  • Kanyakula T; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: tkanyakula@bhp.org.bw.
  • Palalani G; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: gpalalani@bhp.org.bw.
  • Phakedi I; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: phakedi@bhp.org.bw.
  • Taylor S; Infection Evidence Strategy, Vaccine and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK. Electronic address: sylvia.taylor@astrazeneca.com.
  • Mmalane M; Botswana Harvard AIDS Institute Partnership, Botswana. Electronic address: mmmalane@bhp.org.bw.
  • Moyo S; Botswana Harvard AIDS Institute Partnership, Botswana; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, United States. Electronic address: smoyo@bhp.org.bw.
  • Makhema J; Botswana Harvard AIDS Institute Partnership, Botswana; Harvard T.H. Chan School of Public Health, Department of Immunology and Infectious Diseases, Boston, United States. Electronic address: jmakhema@bhp.org.bw.
J Infect ; 86(6): 603-606, 2023 06.
Article in English | MEDLINE | ID: covidwho-2280968
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / ChAdOx1 nCoV-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: J Infect Year: 2023 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / ChAdOx1 nCoV-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: J Infect Year: 2023 Document Type: Article